Numerous individuals who have COVID-19 experience respiratory problems, necessitating escalating measures. Initially, patients were given invasive ventilation as part of the therapy for severe respiratory failure because it was considered more successful than non-invasive ventilation (NIV). Emerging data suggest that non-invasive ventilation (NIV) treatments have a more significant and beneficial role than previously believed. Continuous Positive Airway Pressure (CPAP) and Bi-Level Positive Airway Pressure are included in NIV (BiPAP). For those with complicated respiratory problems who contract COVID-19, BiPAP can help to stabilize their current conditions until they get invasive treatments. Different viewpoints on employing BiPAP in treating dangerous respiratory conditions in COVID patients have made its usage controversial.
According to current data, NIV and HFNO may be useful bridging supplements in the course of the disease and may avoid the necessity for invasive ventilation or intubation. In addition, patients requiring NIV, such as BiPAP treatment, may get nursing care in critical or intensive care units.… Read more “When Is BiPAP Used for COVID?”